Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$53.39 USD
+1.55 (2.99%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $59.50 +6.11 (11.44%) 4:36 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Mirum Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MIRM 53.39 +1.55(2.99%)
Will MIRM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MIRM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MIRM
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
MIRM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mirum Gains 35% in 3 Months: How Should You Play the Stock?
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
Why Is Editas (EDIT) Up 40% Since Last Earnings Report?
Other News for MIRM
Here are the major earnings after the close Wednesday
Earnings Scheduled For August 6, 2025
Mirum Pharmaceuticals reports Q2 EPS (12c), consensus (33c)
ClearBridge Small Cap Growth Portfolios Q2 2025 Commentary
ClearBridge Small Cap Growth Fund Q2 2025 Commentary